xinhua silk road logo xinhua silk road logo
Subscribe CustomBlackClose

Belt & Road Weekly Subscription Form

download_pop

Research ReportCustomBlackClose

The full edition of the report is available at Xinhua Silk Road Database. You can click the “Table of Content” to have a general understanding of it.

Click on the button below to create your account and get immediate access to thousands of articles.

Start a Free Trial

maritime silk road search
Company

Lepu Medical to inject USD12.5 mln into American company Rgenix

October 10, 2018


Abstract : Lepu Medical Technology (Beijing) Co., Ltd. announced that it plans to invest 12.5 million U.S. dollars to join in series C funding of American biopharmaceutical company Rgenix.

041118_JBascom_2T0A5934-1024x683-650x650

BEIJING, Oct. 10 (Xinhua) -- Lepu Medical Technology (Beijing) Co., Ltd. announced that it plans to invest 12.5 million U.S. dollars to join in series C funding of American biopharmaceutical company Rgenix.

According to a company filing, it would like to introduce first in-class drugs, including RGX-104 into China, conducting clinical trials and market development in the country.

The introduction of Rgenix's products not only complements the company's product line of cancer immunotherapy, but also forms a combination of tumor immunotherapy products with its own characteristics, enhancing the company's core competitiveness in tumor immunotherapy. (Edited by Ma Xin, [email protected])

Ask Us A Question belt & road login close

If you have any questions, please enter them in the box below.

Reload

Write to Us belt & road login close

Do you want to be a contributor to Xinhua Silk Road and tell us your Belt & Road story? Send your articles to [email protected] and share your stories with more people.

Click on the button below to create your account and get im http://img.silkroad.news.cn/templates/silkroad/en2017te access to thousands of articles.

Start a Free Trial